Phoxilium 1.2 mmol/l phosphate Solution for haemodialysis/haemofiltration Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

phoxilium 1.2 mmol/l phosphate solution for haemodialysis/haemofiltration

gambro lundia ab - calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride ph.eur.; sodium hydrogen carbonate; potassium chloride; disodium phosphate dihydrate - solution for haemodialysis/haemofiltration - 1.2 mmol/l - hemofiltrates

TETAVAX, suspension for injection in multidose presentation, adsorbed tetanus vaccine Մալթա - անգլերեն - Medicines Authority

tetavax, suspension for injection in multidose presentation, adsorbed tetanus vaccine

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - tetanus toxoid - suspension for injection - tetanus toxoid 40 iu - vaccines

Lutrate 1 month Depot 3.75 mg powder and solvent for prolonged-release suspension for injection Միացյալ Թագավորություն - անգլերեն - myHealthbox

lutrate 1 month depot 3.75 mg powder and solvent for prolonged-release suspension for injection

mercury pharmaceuticals limited - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 3.75 mg - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - lutrate 1 month depot is indicated for palliative treatment of locally advanced or metastatic prostate cancer.

Lutrate 3 month Depot 22.5 mg powder and solvent for prolonged-release suspension for injection Միացյալ Թագավորություն - անգլերեն - myHealthbox

lutrate 3 month depot 22.5 mg powder and solvent for prolonged-release suspension for injection

mercury pharmaceuticals limited - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection. - 22.5 mg - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - lutrate 3 month depot is indicated for palliative treatment of hormone dependent advanced prostate cancer.